Biotech

All Articles

Rivus' period 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing medicati...

Ovid halts preclinical job, IV program after soticlestat stop working

.Ovid Therapy actually disclosed final month that it was trimming its headcount as the provider brow...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has actually opened up a $700 thousand R&ampD center in the Boston ma Seaport, improving ...

Boundless Biography makes 'modest' cutbacks 5 months after $100M IPO

.Only 5 months after securing a $100 million IPO, Boundless Bio is actually giving up some employees...

Halda's $126M will certainly evolve 'secure and get rid of' cyst drugs

.The initial phases of oncology R&ampD aren't short of intriguing brand-new methods, and also Halda ...

Lykos 'regrets' certainly not making known research study offenses along with author

.Psychopharmacology has taken 3 write-ups concerning midstage clinical test data determining Lykos R...

Analysts examine Avidity's DMD win, exposing subtleties in data

.Avidity Biosciences impressed entrepreneurs with stage 1/2 records in Duchenne muscular dystrophy (...

Actinogen's cortisol blocker neglects period 2 clinical depression study

.Actinogen Medical's cortisol blocker has skipped the major endpoint of a stage 2 research study in ...

Bivictrix decides going private only way to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of lots of a billion-dollar biob...

TPG bests up funds to $580M for investments all over lifestyle sciences

.Resource manager TPG, which has actually sustained biotechs including Sionna Therapies as well as S...